Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers
- DOI
- 10.1172/jci152670
- Published
- 2021-12-15
- Container
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1172/jci152670,
title = {Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers},
author = {Mark Yarchoan and Leslie Cope and Amanda N. Ruggieri and Robert A. Anders and Anne M. Noonan and Laura W. Goff and Lipika Goyal and Jill Lacy and Daneng Li and Anuj K. Patel and Aiwu R. He and Ghassan K. Abou-Alfa and Kristen Spencer and Edward J. Kim and S. Lindsey Davis and Autumn J. McRee and Paul R. Kunk and Subir Goyal and Yuan Liu and Lauren Dennison and Stephanie Xavier and Aditya A. Mohan and Qingfeng Zhu and Andrea Wang-Gillam and Andrew Poklepovic and Helen X. Chen and Elad Sharon and Gregory B. Lesinski and Nilofer S. Azad},
year = {2021},
journal = {Journal of Clinical Investigation},
doi = {10.1172/jci152670},
url = {https://doi.org/10.1172/jci152670}
}RIS
TY - JOUR TI - Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers AU - Mark Yarchoan AU - Leslie Cope AU - Amanda N. Ruggieri AU - Robert A. Anders AU - Anne M. Noonan AU - Laura W. Goff AU - Lipika Goyal AU - Jill Lacy AU - Daneng Li AU - Anuj K. Patel AU - Aiwu R. He AU - Ghassan K. Abou-Alfa AU - Kristen Spencer AU - Edward J. Kim AU - S. Lindsey Davis AU - Autumn J. McRee AU - Paul R. Kunk AU - Subir Goyal AU - Yuan Liu AU - Lauren Dennison AU - Stephanie Xavier AU - Aditya A. Mohan AU - Qingfeng Zhu AU - Andrea Wang-Gillam AU - Andrew Poklepovic AU - Helen X. Chen AU - Elad Sharon AU - Gregory B. Lesinski AU - Nilofer S. Azad PY - 2021 JO - Journal of Clinical Investigation DO - 10.1172/jci152670 UR - https://doi.org/10.1172/jci152670 ER -
APA
Yarchoan, M., Cope, L., Ruggieri, A. N., Anders, R. A., Noonan, A. M., Goff, L. W., Goyal, L., Lacy, J., Li, D., Patel, A. K., He, A. R., Abou-Alfa, G. K., Spencer, K., Kim, E. J., Davis, S. L., McRee, A. J., Kunk, P. R., Goyal, S., Liu, Y., Dennison, L., Xavier, S., Mohan, A. A., Zhu, Q., Wang-Gillam, A., Poklepovic, A., Chen, H. X., Sharon, E., Lesinski, G. B., & Azad, N. S. (2021). Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers. Journal of Clinical Investigation. https://doi.org/10.1172/jci152670
Source records
- crossref · retrieved 2026-09-25T03:53:05.580Z